generics

Dr. Reddy’s US generics enterprise drags Q1 earnings, eyes weight-loss drug launch in 87 international locations

by

[ad_1] Dr Reddy’s Laboratories Ltd’s US generics enterprise slumped within the June quarter because it confronted value erosion in key merchandise like gRevlimid used to deal with most cancers. US generics income declined 11% year-on-year and 4% sequentially to ₹3,412 crore within the first quarter of FY26, based on earnings introduced on Wednesday. The enterprise … Read more

Wockhardt exits its US generics business

by

[ad_1] Wockhardt Ltd is exiting its loss-making US generics business, as it focuses on its new antibiotics drug discovery and insulin portfolios. The drugmaker said on Friday that it has made a Chapter 7 filing for voluntary liquidation of its US subsidiaries Morton Grove Pharmaceuticals Inc. and Wockhardt USA LLC. The business has been incurring … Read more